3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with naloxone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bespalov, AY; Blokhina, EA; Sukhotina, IA | 1 |
| Bespalov, AY; Medvedev, IO; Sukhotina, IA; Zvartau, EE | 1 |
| Maeda, A; Minami, M; Nakagawa, T; Satoh, M; Watanabe, T; Yamamoto, R | 1 |
3 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and naloxone
| Article | Year |
|---|---|
Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Topics: Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Male; Memantine; Mice; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Piperazines; Receptors, N-Methyl-D-Aspartate | 2000 |
Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats.
Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2001 |
Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amygdala; Analysis of Variance; Animals; Avoidance Learning; Cerebellar Nuclei; Conditioning, Psychological; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Substance Withdrawal Syndrome | 2002 |